Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with ...

What seems certain is that space and low-orbit laboratories will become an integral tool for drug innovation within the ...

This case study explores challenges, requirements, and more in adopting next-gen technologies to maintain an edge in process ...

Contract development and manufacturing organization (CDMO) Matica Biotechnology has partnered with Calidi Biotherapeutics to ...

Explore the latest news and expert commentary by Alexander Seyf, brought to you by the Contributor of BioProcess ...

Biomanufacturing outsourcing growth is slowing, but political uncertainties, tariffs, and labor shortages are reshaping where ...

Figure 1A: Antibody–drug conjugate (ADC) structure and delivery pathways; linker chemistry determines the mechanism by which cytotoxin release occurs. This schematic shows a monoclonal antibody (MAb) ...

The biopharmaceutical industry is at the forefront of technological advancements, with “biopharma 4.0” revolutionizing the way biomanufacturing is conducted (1). The concept combines automation, ...

Figure 1: Hierarchical model schematic; information from all base-level models is communicated to a top-level model through their respective matrices (T j) into a consensus matrix R. R is used to ...

Figure 1: Monoclonal antibodies (MAbs) exert their biological effects through both Fab‑and Fc-mediated activities. The complexities of biomanufacturing combined with heterogeneity introduced by ...

Figure 1: Physical and procedural model implementation based on principle 88 of International Society for Automation (ISA) standards for batch process control Automation can improve efficiency, track ...

Biologics such as monoclonal antibodies (mAbs), other recombinant proteins, and viral vectors now represent a major class of pharmaceuticals. Their manufacturing, based primarily on mammalian-cell ...